(3-Methoxypyrazin-2-yl)methanamine hydrochloride, 95+%, 250mg

(3R,4R)-1-(tert-Butoxycarbonyl)-4-methylpyrrolidine-3-carboxylic acid, 95.0%, 500mg

2-Bromo-4-(trifluoromethoxy)aniline, 98.0%, 500g

5-amino-4-cyano-N,N,3-trimethylthiophene-2-carboxamide, 95.0%, 1g

2-Chloro-5-(trifluoromethyl)anisole, 95.0%, 5g

2-(3-Methoxy-4-nitrophenyl)acetic acid, 95.0%, 2.5g

Tapón con vidrio hueco cónico estándar, 24/29, 10 Unidad(es)

Methyl 2-acetoxypropanoate, 98%, 1g

5-Bromo-6-methoxybenzo[b]thiophene-2-carboxylic acid, 98%, 1g

4-Bromo-1-(2-hydroxyethyl)pyridin-2(1H)-one, 98%, 500mg

6-Isopropoxy-2-methylpyridine-3-boronic acid, 98%, 1g

2-Bromo-5-methoxyphenol, 95.0%, 10g

3,5,5-Trimethylhexanoic acid; >95%, 98.0%, 100g